PHILADELPHIA (June 14, 2010) – The University City Science Center announced the appointment of eight new members to its Board of Directors at its annual Shareholders Meeting on June 11:
- Kenneth J. Blank, Ph.D., Senior Vice Provost, Temple University
- Christopher Cashman, Chairman, MBF Therapeutics and Director, Noble Biomaterials
- Katherine Crothall, Ph.D., Principal, Liberty Venture Partners
- James A. Datin, Executive Vice President and Managing Director, Life Sciences Group, Safeguard Scientifics
- Steven J. Fluharty, Ph.D., Vice Provost for Research, University of Pennsylvania
- Jane H. Hollingsworth, CEO, NuPathe
- Osagie O. Imasogie, Senior Managing Partner, Phoenix IP Ventures
- Paul Touhey, President & CEO, Fujirebio Diaignostics, Inc.
Blank, Cashman, Crothall, Datin, Fluharty, Hollingsworth, Imasogie and Touhey join the following members of the Science Center Board:
- Maxine Ballen, President and CEO, New Jersey Technology Council
- Richard A. Bendis, President & CEO, Innovation America
- Craig R. Carnaroli, Executive Vice President, University of Pennsylvania
- Ernest Dianastasis, Managing Director, Computer Aid Inc. (CAI) and Chair, First State Innovation
- Michael A. DiPiano, Managing General Partner, New Spring Ventures
- Glen N. Gaulton, Ph.D., Professor of Pathology and Laboratory Medicine, Executive Vice Dean and Chief Scientific Officer, University of Pennsylvania School of Medicine
- Philip P. Gerbino, Pharm.D., President and Linwood F. Tice Professor of Pharmacy, University of the Sciences in Philadelphia
- David P. Holveck, President, CEO and Director, Endo Pharmaceuticals
- Richard P. Jaffe, Esquire (Chairman), Partner, Ballard Spahr
- Philip R. Johnson, MD, Chief Scientific Officer, Executive Vice President and Director of the Joseph Stokes, Jr. Research Institute, The Children’s Hospital of Philadelphia
- Russel E. Kaufman, MD, President & CEO, The Wistar Institute
- David R. King, Venture Partner, Quaker BioVentures
- Carl Kopfinger, Senior Vice President, TD Bank
- Kenneth L. Kring, Managing Director, Korn/Ferry International
- C.R. “Chuck” Pennoni, Interim President, Drexel University
- Arthur H. Rubenstein, MBBCh, Executive Vice President, University of Pennsylvania for the Health System; Dean, University of Pennsylvania School of Medicine
- Tara L. Weiner, Managing Partner, Greater Philadelphia Region, Deloitte LLP.
- Stephen S. Tang, President and CEO, University City Science Center
About The Science Center The University City Science Center accelerates technology commercialization, regional economic development, and the market availability of life‐enhancing scientific breakthroughs by bringing together innovations, scientists, entrepreneurs, funding, laboratory facilities, and business services. Established in 1963 and headquartered in Philadelphia, PA, the Science Center was the first, and remains the largest, urban research park in the United States. Graduate organizations and current residents of the University City Science Center’s Port business incubators have created more than 15,000 jobs that remain in the Greater Philadelphia region today and contribute more than $9 billion to the regional economy annually. For more information about the Science Center, go to www.sciencecenter.org.
